Bone Tumor, Primary Malignant

Bone Tumor, Primary Malignant is a topic covered in the 5-Minute Clinical Consult.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Basics

Description

  • Primary malignant bone tumors are rare (<1% of all tumors). In >40, rule out more common metastatic disease (breast, lung, prostate, thyroid, kidney).
  • Osteogenic sarcomas arise from mesenchymal cells capable of differentiating into bone, cartilage, or fibrous tissue. The three histologic types are:
    • Osteosarcoma: characterized by the production of osteoid or immature bone by malignant cells
    • Chondrosarcoma: cellular cartilaginous tumor with abundant binucleate cells, myxoid areas, pushing borders; lacks osteoid
    • Fibrosarcoma: spindle cells and collagen; no osteoid
  • Ewing sarcoma: small, round blue-cell neoplasm of unknown histologic origin
  • Malignant fibrous histiocytoma (MFH): pleomorphic sarcoma; 10-year survival 20% for high-grade, 90% for low-grade
  • Giant cell tumor of bone (GCTB) has both benign (90%) and malignant forms; prefers epiphyseal long bone, often recurs; 5–10% of primary bone tumors; very destructive
  • Chordoma develops from remnants of primitive notochord at base of skull or sacrum; rare; slowly progressive; recurrent; cure possible

Epidemiology

Incidence
  • Rare: Estimated 2,970 primary bone tumors will be diagnosed in the United States in 2015; 1,490 deaths
  • In adults: most common osteosarcoma (35%), chondrosarcoma (30%), Ewing sarcoma (16%)
  • In resource-rich populations: Malignant bone tumors represent 3–5% of cancers diagnosed in children ages 0 to 14 years of age and 7–8% of cancers in adolescents 15 to 19 years of age (1)[A]; third most common childhood cancer (after leukemia and brain tumor)
  • In children: most common is osteosarcoma (52%); Ewing sarcoma (34%) second; and chondrosarcoma third.
  • Predominant age
    • Osteosarcoma: bimodal: ages 13 to 16 years and >65 years
    • Chondrosarcoma: 3rd to 7th decades
    • Fibrosarcoma: 2nd to 6th decades
    • Ewing sarcoma: children and teen aged 10 to 15 years (70% of Ewing patients <20 years of age)
    • MFH: adults and elderly
    • GCTB: skeletally mature young adult in 2nd to 4th decades
    • Chordoma: >40 years
  • Predominant gender
    • For most, male = female
    • Osteosarcoma, male > female (1.5:1); Ewing sarcoma, male > female; chondrosarcoma, male > female (2:1); chordoma, males > females
  • Race
    • Ewing sarcoma is more common in Caucasian than in African American children.
    • Osteosarcoma is slightly more common in African American than in Caucasian children.

Etiology and Pathophysiology

  • Generally unknown but likely multifactorial
  • Chondrosarcoma may arise in preexisting enchondroma or exostosis.
  • MFH often follows irradiation or arises in old bone infarct.
  • GCTB RANKL-RANK-OPG signal pathway involved

Genetics
  • Genetic risk factors include:
    • Paget disease: osteosarcoma
    • Multiple hereditary exostosis: chondrosarcoma
    • Multiple enchondromatosis (Ollier disease): chondrosarcoma
    • Enchondromatosis and hemangiomatosis (Maffucci syndrome): chondrosarcoma
      • Germline retinoblastoma, especially after radiation: osteosarcoma
      • Li-Fraumeni syndrome (germline p53 or CHEK2 mutation): osteosarcoma
      • Rothmund-Thomson syndrome (autosomal recessive): osteosarcoma
      • RAPADILINO syndrome: osteosarcoma
      • Diamond-Blackfan anemia (disorder of bone marrow): osteosarcoma
  • Tumor genetics
    • Ewing sarcoma has chromosomal translocation t(11;22) (q24;q12) in 90% of tumors and resulting EW5-FLI1 fusion protein. Mutation in the EWSR1 causes Ewing sarcoma (somatic mutation).
    • Osteosarcoma shows loss of retinoblastoma 1 gene (RB1) and p53 suppressor genes and amplification of the genes c-myc, mdm-2, SAS, and cyclin-dependent kinase.

Risk Factors

  • High fluoride exposure, residing on farmland (1)[A]
  • Previous irradiation is a risk factor for osteosarcoma and MFH.
  • Rapid bone growth, teenage growth spurt
  • Fibrous dysplasia, uncommon genetic disorder

Commonly Associated Conditions

  • Genetic conditions listed previously
  • Patients with enchondromatosis more often die of GI malignancies than of metastatic chondrosarcoma.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Bone Tumor, Primary Malignant ID - 816401 ED - Baldor,Robert A, ED - Domino,Frank J, ED - Golding,Jeremy, ED - Stephens,Mark B, BT - 5-Minute Clinical Consult, Updating UR - https://im.unboundmedicine.com/medicine/view/5-Minute-Clinical-Consult/816401/all/Bone_Tumor__Primary_Malignant PB - Wolters Kluwer ET - 27 DB - Medicine Central DP - Unbound Medicine ER -